PP
JAZZ icon

PDT Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

PDT Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,236
Closed -$289K – 602
2023
Q3 		$289K Sell
2,236
-7,825
-78% -$1.04M 0.04% 484
2023
Q2 		$1.25M Hold
10,061
– – 0.17% 198
2023
Q1 		$1.47M Buy
+10,061
New +$1.49M 0.2% 181
2022
Q4 		– Sell
-6,562
Closed -$875K – 763
2022
Q3 		$875K Buy
6,562
+2,520
+62% +$383K 0.13% 260
2022
Q2 		$631K Buy
+4,042
New +$622K 0.06% 539
2021
Q2 		– Sell
-27,402
Closed -$4.5M – 884
2021
Q1 		$4.5M Sell
27,402
-2,179
-7% -$359K 0.32% 85
2020
Q4 		$4.88M Sell
29,581
-4,600
-13% -$685K 0.33% 131
2020
Q3 		$4.87M Sell
34,181
-19,500
-36% -$2.42M 0.32% 129
2020
Q2 		$5.92M Sell
53,681
-32,335
-38% -$3.58M 0.4% 102
2020
Q1 		$8.58M Buy
86,016
+19,616
+30% +$2.54M 0.68% 30
2019
Q4 		$9.91M Buy
66,400
+11,600
+21% +$1.58M 0.61% 36
2019
Q3 		$7.02M Buy
+54,800
New +$7.35M 0.42% 99
2015
Q4 		– Sell
-37,994
Closed -$5.05M – 677
2015
Q3 		$5.05M Buy
+37,994
New +$6.54M 0.11% 226
2015
Q2 		– Sell
-46,381
Closed -$8.01M – 1481
2015
Q1 		$8.01M Buy
+46,381
New +$7.96M 0.2% 125
2014
Q4 		– Sell
-3,829
Closed -$615K – 862
2014
Q3 		$615K Buy
+3,829
New +$589K 0.02% 876
2014
Q2 		– Sell
-16,334
Closed -$2.27M – 1510
2014
Q1 		$2.27M Buy
+16,334
New +$2.46M 0.05% 419
2013
Q4 		– Sell
-3,800
Closed -$349K – 893
2013
Q3 		$349K Buy
+3,800
New +$307K 0.01% 1193

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PDT Partners's JAZZ Position: Q4 2023 in Review

PDT Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 2,236 shares — an estimated $289K sold.

PDT Partners first reported a position in JAZZ in Q3 2013 and held it in 17 quarters. The position peaked at $9.91M in Q4 2019. 500 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

  • PDT Partners reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • PDT Partners sold 2,236 Jazz Pharmaceuticals shares in Q4 2023, an estimated $289K.
  • PDT Partners first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 17 quarters.
  • PDT Partners's Jazz Pharmaceuticals position peaked at $9.91M in Q4 2019.
  • 500 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on PDT Partners's 13F filing for Q4 2023, filed 14 Feb 2024.